BioMarin Pharmaceutical Inc. (BMRN): $75.51

-0.09 (-0.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BMRN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

Biomarin Pharmaceutical Inc (BMRN) Price Targets From Analysts

Use the tables below to see what analysts covering Biomarin Pharmaceutical Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
18 $183 $82 $108.39 $80.46 34.71%

The Trend in the Analyst Price Target


BMRN's average price target has moved down $2.88 over the prior 248 days.

BMRN reports an average of 28.58% for its upside potential over the past 325 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 18 183 82 108.39 78.73 37.67%
2021-04-17 18 183 82 108.39 79.40 36.51%
2021-04-10 19 183 81 107.11 77.07 38.98%
2021-04-03 19 183 81 107.11 77.83 37.62%
2021-03-20 19 183 81 107.11 78.18 37%
2021-03-13 19 183 81 107.11 76.77 39.52%
2021-03-06 20 183 81 107.25 77.73 37.98%
2021-02-27 19 185 81 107.58 77.43 38.94%
2021-02-20 20 188 84 110.95 81.76 35.7%
2021-02-13 20 188 84 110.95 87.04 27.47%
2021-02-06 20 188 84 110.95 85.22 30.19%
2021-01-30 20 188 84 110.90 82.78 33.97%
2021-01-23 20 188 84 110.90 87.99 26.04%
2021-01-16 20 188 84 110.90 82.97 33.66%
2021-01-09 20 188 84 110.15 89.86 22.58%
2021-01-02 21 188 80 108.71 87.69 23.97%
2020-12-26 21 188 80 108.24 88.66 22.08%
2020-12-19 21 188 80 108.24 88.85 21.82%
2020-12-09 21 188 80 108.24 76.16 42.12%
2020-12-07 21 188 80 108.24 78.39 38.08%
2020-11-23 22 187 80 108.73 77.04 41.13%
2020-11-06 22 187 80 108.73 76.74 41.69%
2020-10-08 22 188 80 110.91 79.61 39.32%
2020-09-17 23 188 80 111.52 78.36 42.32%
2020-08-20 22 188 80 111.27 74.85 48.66%
2020-08-13 22 218 108 136.91 116.87 17.15%
2020-08-05 22 172 108 134.82 119.83 12.51%
2020-07-23 22 165 94 128.00 124.49 2.82%
2020-07-14 22 165 94 127.32 126.43 0.7%
2020-07-03 23 165 77 125.13 126.78 -1.3%
2020-06-17 23 165 77 123.26 111.32 10.73%
2020-06-10 23 165 77 121.48 107.66 12.84%
2020-06-04 23 165 77 121.04 107.51 12.58%

BMRN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 6 8 6 0 0 20

The Trend in the Broker Recommendations


Over the past 61 days, BMRN's average broker recommendation rating worsened by 0.17.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The variance in analysts' estimates of BMRN is less than 6.05% of all US stocks.
  • The number of analysts covering the stock of BMRN is higher than 96.19% of Pharmaceutical Products stocks.
  • Biomarin Pharmaceutical Inc's upside potential (average analyst target price relative to current price) is greater than 93.8% of stocks in the large market cap category.
  • Biomarin Pharmaceutical Inc's average analyst price target is higher than 92.68% of Pharmaceutical Products stocks.

Stocks similar to Biomarin Pharmaceutical Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FATE, JNJ and BMY.

Make investment decisions regarding BMRN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9634 seconds.